EF
EBS icon

Empowered Funds’s Emergent Biosolutions EBS Stock Holding History

Empowered Funds’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,524
Closed -$143K – 1392
2023
Q4 		$143K Buy
59,524
+5,352
+10% +$12.6K ﹤0.01% 1229
2023
Q3 		$184K Buy
+54,172
New +$300K 0.01% 1163
2020
Q4 		– Sell
-11,676
Closed -$1.21M – 176
2020
Q3 		$1.21M Buy
+11,676
New +$1.26M 0.38% 103

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Empowered Funds's EBS Position: Q1 2024 in Review

Empowered Funds sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 59,524 shares — an estimated $143K sold.

Empowered Funds first reported a position in EBS in Q3 2020 and held it in 3 quarters. The position peaked at $1.21M in Q3 2020. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Empowered Funds reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Empowered Funds sold 59,524 Emergent Biosolutions shares in Q1 2024, an estimated $143K.
  • Empowered Funds first reported a position in Emergent Biosolutions in Q3 2020 and held it in 3 quarters.
  • Empowered Funds's Emergent Biosolutions position peaked at $1.21M in Q3 2020.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Empowered Funds's 13F filing for Q1 2024, filed 6 May 2024.